A study that underlined the effectiveness of a blood pressure drug manufactured by Novartis is being withdrawn by a Japanese University after it admitted that the study was based on data that was fabricated. The move was the latest chapter in a growing scandal over allegations that bogus data were used in a string of Japanese university studies for the drug Valsartan which exaggerated its effectiveness in preventing strokes and angina. On Wednesday, ...Thursday, 1 August 2013
Japanese University Says Study on Novartis' Blood Pressure Drug Based on Fabricated Data
A study that underlined the effectiveness of a blood pressure drug manufactured by Novartis is being withdrawn by a Japanese University after it admitted that the study was based on data that was fabricated. The move was the latest chapter in a growing scandal over allegations that bogus data were used in a string of Japanese university studies for the drug Valsartan which exaggerated its effectiveness in preventing strokes and angina. On Wednesday, ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment